In Alzheimer’s patients, insulin resistance in the brain, particularly in the hippocampus, characterized by elevated insulin receptor substrate 1 (IRS-1) serine phosphorylation [43], is linked to disrupted insulin signaling and reduced PI3K/Akt activity. The gene discussed is IRS1; the disease is Insulin resistance.